$5.52
-0.12-2.13%
At Close: -
$5.52
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
TScan Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TScan Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.28 | $-0.28 | 0.00 % |
Mar 2024 | 2024-05-13 | $-0.32 | $-0.25 | -28.0 % |
Dec 2023 | 2024-03-06 | $-0.21 | $-0.29 | 27.6 % |
Sep 2023 | 2023-11-09 | $-0.24 | $-0.45 | 46.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $536.00K | $2.42M | -77.8 % |
Mar 2024 | 2024-05-13 | $566.00K | $3.97M | -85.7 % |
Dec 2023 | 2024-03-06 | $7.21M | $3.34M | 115.9 % |
Sep 2023 | 2023-11-09 | $3.89M | $4.09M | -4.96 % |
TScan Therapeutics (TCRX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.28, which hit the estimate of $-0.28.
The Actual Revenue was $536K, which missed the estimate of $2.4M.
Browse earnings estimates, EPS, and revenue on all stocks.